1 / 1

Kim Myung-ki: Bio Industry Valuation

$74.00USD
1
Free Priority FedEx · on orders over $300
Shipping available to United States
Estimated arrivalNov 13 – Nov 16
Exact shipping options and rates are shown at checkout.
From South Korea
In stock
From United States
Unavailable
Description

The safety of the bio-drug industry from an investment perspective. If you start off as a drug development researcher and follow a large picture of the bio-drug industry that is used by the author for 20 years of drug development funds on the ground, you can catch up with the flow and context of value evaluations.

Korean title: 바이오 인더스트리 밸류에이션

Korean author: 김명기

Korean publisher: 바이오스펙테이터

ISBN-13: 9791196079383

Reviews

4.7
Based on 14 reviews
Showing 4 of 14 reviews
DJ********
June 12, 2025

It's hard to read, but it'll be easier if you keep looking at it. It helps.

OJ*****
December 13, 2020

It helps us understand the bio-insult. I urge you to know about the bio-insurance.

AR****
October 10, 2020

You don't call this book? The material is true and false, except for the bridge, and the translation is so frequent that it's really unreadable. Read it to those of you who have invested.

PI******
June 19, 2020

When I first did a bioinvestment, I decided that I needed a lot of knowledge about medicine. So I'm going to buy some books and work hard to explain all kinds of medical education and all sorts of things about the body. I had to say it. But soon I realized it wasn't efficient. What we needed as investors was not general medical knowledge. It took understanding of the whole of drug development, but it was hard to find such a book. This was a very pleasant and interesting book in that sense. The

김명기: 바이오 인더스트리 밸류에이션
12 items